News from CRISPR
Stay current with all the latest and breaking news about CRISPR, compare headlines and perspectives between news sources on stories happening today. In total, 56 stories have been published about CRISPR which Ground News has aggregated in the past 3 months.
Covered Most By
Suggest a source
Looking for a source we don't already have? Suggest one here.Top CRISPR News
Latest News Stories
CRISPR · WürzburgThe antimicrobial potential of CRISPR-Cas systems is promising, yet how to best design or implement CRISPR nucleases remains poorly understood. An international team led by the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg has now addressed this knowledge gap.See the Story
Researchers systematically investigate efficacy of CRISPR antimicrobial agents
100% Center coverage: 1 sources
CRISPR · WashingtonNorth Korea is capable of engineering bioweapons for military purposes with gene-editing technology like CRISPR, according to a new U.S. government report, highlighting possible efforts to advance the country’s secretive biowarfare program. The State Department’s 2024 Adherence to and Compliance with Arms Control, Nonproliferation and Disarmament Agreements and Commitments report released on Monday warns that […]See the Story
North Korea can use gene-editing tech to craft military bioweapons, US warns
100% Center coverage: 1 sources
CRISPR · CaliforniaThe Food and Drug Administration (FDA) approved the gene therapy Casgevy in December, which uses CRISPR/Cas9 genome editing technology to treat sickle-cell disease (SCD) in patients twelve years and older. The drug, also called “exa-cel,” is the first gene-editing medical treatment to be FDA-approved. Two Stanford faculty were closely involved with the process: Stanford Professor of Pediatrics Matthew Porteus M.D. Ph.D ’94 pioneered a method of…See the Story
Stanford doctors develop first FDA-approved gene-editing treatment
100% Left coverage: 1 sources
CRISPRPrime editing enables the precise modification of genomes through reverse transcription of template sequences appended to the 3′ ends of CRISPR–Cas guide RNAs1. To identify cellular determinants of prime editing, we developed scalable prime editing reporters and performed genome-scale CRISPR-interference screens. From these screens, a single factor emerged as the strongest mediator of prime editing: the small RNA-binding exonuclease protection f…See the Story
Improving prime editing with an endogenous small RNA-binding protein
100% Center coverage: 1 sources
CRISPR · United StatesCRISPR Therapeutics, a leader in gene therapies, achieves a milestone with the approval of CASGEVY for β-thalassemia and sickle cell disease. Read more here.See the Story
CRISPR: Upcoming Catalysts May Validate The Bull Thesis And Force A Change In Plans (CRSP)
100% Right coverage: 1 sources